The hepatitis delta virus (HDV) has a very limited protein coding capacity and must rely on host proteins for its replication. A ribonucleoprotein complex was detected following UV cross-linking between HeLa nuclear proteins and an RNA corresponding to the right terminal stem-loop domain of HDV genomic RNA. Mass spectrometric analysis of the complex revealed the polypyrimidine tract-binding protein-associated splicing factor (PSF) as a novel HDV RNA-interacting protein. Co-immunoprecipitation demonstrated the interaction between HDV RNA and PSF both in vitro in HeLa nuclear extract and in vivo within HeLa cells containing both polarities of the HDV genome. Analysis of the binding of various HDV-derived RNAs to purified, recombinant PSF further confirmed the specificity of the interaction and revealed that PSF directly binds to the terminal stem-loop domains of both polarities of HDV RNA. Our findings provide evidence of the involvement of a host mRNA processing protein in the HDV life cycle.
Introduction
There is increasing evidence that cellular factors are substantially involved in viral RNA replication and transcription (Lai, 1998 (Lai, , 2005 Taylor, 2006) . These cellular proteins are often associated with RNA-processing pathways or translation machinery, suggesting that RNA viruses might actively subvert normal cellular RNA processing or translation proteins for viral RNA synthesis. This is particularly crucial for the hepatitis delta virus (HDV) which has an extremely small genome and possesses a very limited protein coding capacity (Taylor, 2006) . HDV must thus rely heavily on host components for most steps of its replication and transcription.
HDV has a small (∼ 1700 nucleotides, nt) single-stranded, circular RNA genome and requires the hepatitis B virus (HBV) envelope proteins for encapsidation and dissemination (Chen et al., 1986; Rizzetto et al., 1977; Wang et al., 1986) . Its genome folds into an unbranched, rod-like structure including two selfcleaving motifs (delta motifs; Kuo et al., 1988b) and a single open reading frame (ORF) encoding two viral proteins (HDAgs; Wang et al., 1986; Weiner et al., 1987) . These two proteins are identical in sequence, except that the large HDAg (HDAg-L) contains 19 additional amino acids at its C-terminus resulting from RNA editing of the termination codon of the small HDAg (HDAg-S) gene (Luo et al., 1990; Wong and Lazinski, 2002) . Although they are identical over most of their lengths, each protein has a distinct function. HDAg-S (195 amino acids) is essential for HDV replication (Kuo et al., 1989) , while the HDAg-L (214 amino acids) is necessary for virion assembly and is reported to be a dominant negative inhibitor of replication (Chang et al., 1991) .
In the currently accepted model, HDV replicates in mammalian cells by a symmetrical, rolling circle mechanism (Chen et al., 1986; Taylor, 2006) . Replication of the infectious circular monomer (which is assigned genomic polarity by convention and accumulates at a greater intracellular abundance than the antigenomic species) produces linear, multimeric Virology 356 (2006) 35 -44 www.elsevier.com/locate/yviro strands which are subsequently self-cleaved and ligated, yielding antigenomic polarity circular monomers. Using the latter RNAs as templates, the same three steps are repeated to generate the genomic progeny. Nuclear RNA polymerase II (RNAP II) is considered to be involved in the replication and transcription of HDV. HDAg mRNA has a distinct 5′-end and is post-transcriptionally processed with a 5′-cap and a 3′-poly(A) tail (Gudima et al., 2000) , which are typical features of transcripts generated by RNAP II. Low doses of α-amanitin, a mycotoxin that specifically inhibits DNA-dependent RNA transcription by RNAP II, inhibit the accumulation of HDV mRNA and processed unit-length genomic RNA species in infected cells (Fu and Taylor, 1993; Macnaughton et al., 1991) . Additionally, in in vitro transcription assays using nuclear extract (NE) from HeLa cells and RNA derived from the left terminal stem-loop domain of HDV antigenomic RNA, synthesis of the complementary strand was possible (Filipovska and Konarska, 2000) . Accumulation of this RNA product was highly sensitive to α-amanitin. This sensitivity was partially abrogated in experiments conducted in NE from cells containing an α-amanitinresistant allele of the largest subunit of RNAP II, suggesting the involvement of RNAP II in this reaction. However, the transcription did not proceed by de novo initiation, but rather by cleavage of the RNA template followed by extension of the new 3′ end, generating a chimeric template/transcript product. Conversely, because the accumulation of the antigenomic species is resistant to higher doses of α-amanitin, it is suggested that the synthesis of the antigenome could be carried out by a polymerase other than RNAP II Modahl et al., 2000) .
To date, few proteins are reported to be associated with HDV. HDAg associates with HDV genomic RNA to form a ribonucleoprotein (RNP) complex in the HDV-containing HBV virion and in transfected cells (Chang et al., 1988; Lin et al., 1990; Ryu et al., 1993) . In addition, HDAg can function as an RNA chaperone and modulate the ribozyme activity of HDV RNA (Huang and Wu, 1998) . Host proteins that were identified to be associated with HDV biology can be divided in two categories: HDAg-or HDV RNA-interacting proteins. The host proteins reported to interact with HDAg are the cellular doublestranded RNA-dependent protein kinase (PKR), nucleolin, and a cellular homolog of HDAg named delta-interacting protein A (DIPA; Brazas and Ganem, 1996; Chen et al., 2002; Lee et al., 1998) . The host proteins observed to interact directly with HDV RNA are PKR, the negative elongation factor (NELF), glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and the small form of adenosine deaminase acting on RNA (ADAR-1; Circle et al., 1997; Robertson et al., 1996; Wong and Lazinski, 2002; Yamaguchi et al., 2002) . ADAR-1 is reported to carry out the post-transcriptional RNA editing of the HDV genome and GAPDH is believe to be involved in the regulation of HDV ribozyme activity (Lin et al., 2000) . However, the physiological significance of the interaction of most of these proteins remains enigmatic and the identification of additional host factors involved in viral replication is required to gain a better understanding of HDV replication.
To identify additional host proteins involved in HDV replication, we analyzed the protein content of a ribonucleoprotein complex produced by UV cross-linking an HDVderived RNA previously reported to act as an RNA promoter in vitro (Beard et al., 1996) to proteins included in NE from HeLa cells. Mass spectrometry of the complex led to the identification of the polypyrimidine tract-binding (PTB) protein-associated splicing factor (PSF) as an HDV-binding protein. Using coimmunoprecipitation with HeLa NE proteins and electrophoretic mobility shift assays (EMSAs) of a series of HDV-derived RNAs with purified, recombinant hexahistidine-tagged PSF, we have found that PSF binds directly to both terminal stem-loop domains of both polarities of HDV RNA. In addition, the interaction between HDV RNA and PSF was demonstrated in vivo using HeLa cells containing both polarities of HDV RNA. Together, these results suggest a role for host mRNA processing proteins in HDV replication and/or propagation and the possible involvement of PSF in the life cycle of HDV.
Results
Formation of a specific complex between the right terminal stem-loop domain of genomic HDV RNA and HeLa NE proteins
In order to identify host proteins that interact with HDV RNA, we used a 208 nt RNA fragment containing 199 nt derived from the right terminal stem-loop domain of the genomic polarity of HDV (R199G; nucleotides 1541 to 61) as bait. We selected this fragment because it includes the reported initiation site for HDAg mRNA transcription (i.e. position 1630; Gudima et al., 2000) and a similar HDV-derived RNA fragment was previously shown to be able to initiate transcription in vitro using HeLa NE proteins (Beard et al., 1996) . In addition, the stem-loop structure conformation of this domain has been confirmed in vitro under approximately physiological conditions (Beard et al., 1996) . Fig. 1 shows the location, the sequence, and the putative secondary structure of the radiolabelled synthetic RNA used as bait in our study.
We performed UV cross-linking assays of internally radiolabelled R199G with proteins contained in HeLa NE. To obtain a better cross-linking yield, photoreactive 4-thio-uridine was randomly incorporated into R199G during its in vitro synthesis. In addition, an excess amount of total yeast tRNA was added to each sample to ensure the specificity of the interaction. Following UV irradiation and treatment with RNase A to remove excess probe, the mixtures were fractionated by SDS-PAGE. UV cross-linking of NE proteins to the radiolabelled bait generated a single major band migrating as a species of approximately 250 kDa (Fig. 2) . This complex was only detected in the presence of NE, indicating that formation of the radiolabelled complex was dependent on the presence of the NE proteins. This complex was also detected in the presence of heparin, poly(A) RNA, and P11.60 RNA as non-specific competitors. P11.60 is a small RNA fragment derived from the terminal stem-loop domain of the peach latent mosaic viroid genome which has been demonstrated to have promoter activity in the presence of the Escherichia coli RNAP (Pelchat and Perreault, 2004) , providing an excellent competitive RNA species for this experiment. As an additional control to test the specificity of the interaction, unlabelled R199G was included in the reaction. Inclusion of a 50-fold molar excess of unlabelled, homologous competitor RNA (i.e. R199G) inhibited formation of the radiolabelled RNA-protein complexes. Together, these observations indicate that at least one protein present in the NE from uninfected HeLa cells is able to bind specifically to the right terminal stem-loop region of genomic HDV RNA.
Identification of the polypyrimidine tract-binding protein-associated splicing factor (PSF) as a protein cross-linked to the HDV RNA fragment
The band corresponding to the UV cross-linked complex between non-radiolabelled R199G and HeLa NE proteins was excised from methylene blue-stained gels (Fig. 2B ), subjected to in-gel trypsin digestion, and the resulting peptides were eluted and analyzed by mass spectrometry (LC-MSMS). At the same time, UV irradiation was performed on a sample without R199G and subjected to the same treatment. This sample was used as a negative control in the identification of the proteins interacting with the HDV-derived RNA. As expected, when the peptide amino acid sequence information was used to search human protein sequence databases, many proteins with high molecular masses were detected. However, three peptides whose protonated masses corresponded to YGEPGEVFINK, LFVGNLPADITEDEFK, and NLSPYVSNELLEEAFSQFG-PIER, matching the 76 kDa human polypyrimidine tractbinding (PTB) protein-associated splicing factor (PSF) were repeatedly detected in the sample containing R199G. This multifunctional protein, also known as splicing factor proline/ glutamine-rich (SFPQ), possesses a DNA-binding domain, two RNA recognition motifs and two nuclear localization sequences (Shav-Tal and Zipori, 2002; Song et al., 2005) . In addition, PSF forms heterodimers with p54 nrb and interacts with many other proteins (Patton et al., 1993; Peng et al., 2002; Shav-Tal and Zipori, 2002) . Notably, PSF is involved in the post-transcriptional regulation of HIV-1 where it is speculated to repress env transcription, mediate nuclear retention, and promote shuttling to the cytosol when complexed with p54 nrb (Zolotukhin et al., 2003) . Nevertheless, this result suggests that PSF is a nuclear protein that can interact with the right terminal stem-loop region of genomic HDV RNA.
The terminal stem-loop domain of both polarities of HDV RNA co-immunoprecipitate with PSF within HeLa NE To demonstrate the association of R199G with PSF, coimmunoprecipitation experiments with anti-PSF antibody were performed on samples containing radiolabelled R199G in HeLa NE. A typical gel is shown in Fig. 3A . A band corresponding to radiolabelled R199G was detected when PSF was immunoprecipitated with the anti-PSF antibody. The interaction of PSF with the HDV probe was considerably abolished by an excess of and HeLa NE proteins. (A) Internally radiolabelled R199G containing 4-thiouridine was UV cross-linked at 365 nm with HeLa NE proteins, treated with RNase A, and resolved by SDS-PAGE. 1 pmol of radiolabelled R199G and 100 μg/ml of total yeast tRNA was used for these experiments. Depending on the assays, 10 μg HeLa NE, heparin (100 μg/ml), poly(A) RNA (100 μg/ml), 20 pmol of P11.60 (Pelchat and Perreault, 2004) , or 50 pmol of non-labelled R199G were used. Indicated protein markers were visualized by Coomassie blue staining. (B) Methylene blue-stained gel of the cross-linking reactions performed with or without 50 pmol of R199G. unlabelled homologous competitor, but not by unrelated competitors including heparin, total yeast tRNA, or P11.60 RNA, clearly indicating the specific interaction of HDV RNA with PSF. This radioactive band was not observed when the experiment was performed in the absence of the anti-PSF antibody, when using HeLa NE depleted of PSF by anti-PSF antibody prior to incubation (i.e. NE-PSF), or when using an unrelated antibody for the immunoprecipitation (i.e. anti-IgG). These observations unambiguously demonstrate that a complex including PSF interacts specifically with R199G within HeLa NE.
In order to establish whether or not PSF interacts with other regions of HDV RNA, radiolabelled RNA transcripts representing various regions of both genomic and antigenomic HDV RNA were synthesized in vitro and used in co-immunoprecipitation experiments as above. The association of these RNA molecules with PSF is summarized in Fig. 3D . Results indicate that RNA regions consisting of the stem-loop domains of both polarities of HDV RNA co-immunoprecipitate with PSF (i.e. R199G, R199AG, L213G, and L213AG), whereas the central regions of both HDV polarites fail to co-immunoprecipitate specifically with PSF (i.e. CENTRG and CENTRAG). To guarantee that both RNA molecules forming the CENTR RNAs annealed, both strands were mixed, heated, slowly cooled, and tested for double-strand formation. Electrophoresis on a native agarose gel confirmed that most of the RNA molecules forming the CENTR RNAs annealed under our conditions (data not shown). These results indicate that PSF associates specifically with HDV RNA at locations included within the terminal stemloop domains of both polarities of HDV RNA within HeLa NE.
PSF directly binds to the terminal stem-loop domains of both polarities of HDV RNA
To confirm the binding of PSF to the HDV-derived RNAs, PSF tagged at its N-terminal end with a hexahistidine peptide was expressed in Escherichia coli and purified by immobilized Ni 2+ affinity chromatography. Purified, recombinant PSF was then used in EMSA experiments. Radiolabelled R199G or the P11.60 negative control were allowed to bind with increasing amounts of PSF for 5 min at 4°C, and then the samples were subjected to electrophoresis through a non-denaturing 5% polyacrylamide gel. A typical gel showing a titration of a constant amount of either radiolabelled R199G or P11.60 with increasing amounts of protein is shown in Fig. 3B . Purified, recombinant PSF binds directly to R199G, as illustrated by the retardation of the migration of the complex when compared to free RNA. Conversely, recombinant PSF does not bind to the unrelated RNA molecule (i.e. P11.60). The binding affinity of PSF for R199G was then determined using this gel. Our results suggest a high dissociation constant (K D ) for the interaction between R199G and PSF (i.e. 0.372 ± 0.031 μM). However, we Co-immunoprecipitation of radiolabelled R199G with PSF in HeLa NE. 1 pmol of radiolabelled R199G was used for these experiments. Depending on the assays, 10 μg HeLa NE, heparin (100 μg/ml), total yeast tRNA (100 μg/ml), 20 pmol of P11.60, 50 pmol of non-labelled R199G, or 25 μg of immunodepleted extract for PSF were used. Lane M contains radiolabelled R199G. (B) Titration of a constant amount of radiolabelled R199G or P11.60 with increasing amounts of hexahistidine-tagged PSF. 0, 0.4, 0.8, 1.2, 1.6, and 2.0 μM 6xHis-PSF or 0, 0.8 and 1.2 μM 6xHis-PSF were used for R199G or P11.60, respectively. (C) EMSA of R199G bound to 4 pmol of hexahistidine-tagged PSF in the presence of either 20 pmol of P11.60, total yeast tRNA (100 μg/ml), poly(A) RNA (100 μg/ml), 50 pmol of non-labelled R199G, or anti-PSF antibody. (D) Interaction of PSF with various HDV-derived RNAs. The polarity of each HDV-derived RNA is indicated. For the RNAs subjected to EMSA analysis, the resulting binding efficiency was quantified densitometrically and compared to R199G (−: <5%, +: 6%-33%, ++: 34%-56%, +++: 57%-79%, ++++: >80%).
found that some of the RNA consistently degraded during the assays, and that this degradation was dependent on protein concentration.
Since a high K D is often associated with a low binding specificity, the binding of R199G to PSF was then studied by competition with either P11.60, yeast total tRNA, poly(A) RNA, or with unlabelled homologous competitors (Fig. 3C) . Binding of recombinant PSF to radiolabelled R199G was abrogated by the addition of unlabelled, homologous competitor RNA, but not by the unrelated competitors. In addition, monoclonal PSF antibody was able to supershift the radiolabelled complex, attesting to the binding of PSF.
Similar EMSA experiments were then conducted with radiolabelled RNAs representing the various regions of the HDV genome used in the co-immunoprecipitation experiments (Fig. 3D ). In correlation with the results obtained using coimmunoprecipitation in HeLa NE, PSF was found to bind specifically to the RNA regions consisting of the stem-loop domains of both polarities of HDV RNA (i.e. R199G, R199AG, L213G, and L213AG), but not to the central regions (i.e. CENTRG and CENTRAG). Although we cannot exclude that additional factors missing in these experiments, such as p54 nrb or HDAg, could facilitate the binding of PSF to the HDVderived RNAs, our results clearly indicate that the recombinant PSF binds directly and specifically to the terminal stem-loop domains of both polarities of HDV RNA.
PSF interacts with HDV RNA in HeLa cells containing both polarities of HDV RNA In vivo, PSF associates with PTBs (Patton et al., 1993) and with the small nuclear U1A ribonucleoprotein (Lutz et al., 1998) . It was also reported to specifically bind U5 snRNA (Peng et al., 2002) and to be associated with a variety of nuclear complexes. The previous experiments clearly indicate specific binding of PSF to the terminal stem-loop domains of both polarities of HDV RNA in vitro. Because PSF and HDV RNA might not interact in a cellular environment where HDV RNA has to compete for PSF binding and where their respective localizations might differ, we decided to investigate the validity of this interaction in vivo. HeLa cells were transfected with a dimeric HDV transcript of genomic polarity. Because HDAg-S is required to initiate HDV RNA replication (Kuo et al., 1989) , the cells were co-transfected with a plasmid transiently expressing HDAg-S from a CMV promoter. Four days posttransfection, cells were harvested and the RNA-protein complexes cross-linked in vivo using a ribonucleoprotein immunoprecipitation (RIP) assay that employs formaldehyde as a reversible cross-linking agent (Niranjanakumari et al., 2002) .
Following cross-linking with formaldehyde and co-immunoprecipitation using anti-PSF antibody, the cross-links were reversed by heating the samples. The RNA was isolated and analyzed by RT-PCR exploiting both primers used to produce the R199G cDNA (Fig. 4) . A band corresponding to the R199G cDNA (i.e. 232 bp) was detected when the cross-linked extract was subjected to co-immunoprecipitation with the anti-PSF antibody. Cloning and subsequent sequence analysis confirmed the identity of the HDV-derived cDNA fragments. However, R199G cDNA was not detected when the experiment was performed in the absence of cross-linking, without anti-PSF antibody, or when an unrelated antibody (i.e. anti-IgG) was used. These results indicate that the band detected when the anti-PSF antibody was used in the co-immunoprecipitation experiment was not resultant of RT-PCR products obtained from non-specific binding of HDV RNA to either the anti-PSF antibody or the protein-G agarose beads, and that it was dependent on the presence of the anti-PSF antibody. The presence of these RNA fragments in the cross-linked, coimmunoprecipitated samples provides evidence that formaldehyde covalently cross-linked HDV RNA to PSF, implicating their interaction in vivo.
The RT-PCR reactions were also designed to differentiate between RNA molecules derived from both polarities of HDV. For instance, the sense and antisense primers used to generate the R199G cDNA were only able to reverse transcribe from either the antigenomic or the genomic polarity of HDV RNA, respectively (Fig. 4, HDV RNA lanes) . Because the RT-PCR reactions were not quantitative, no information about the binding efficiency of PSF to the HDV RNAs was revealed. Since RNA fragments corresponding to both polarities of HDV were detected when the cross-linked extract was co-immunoprecipitated with the anti-PSF antibody, we conclude that PSF associates with both polarities of HDV RNAs within HeLa cells.
Discussion
Previous work from several laboratories has demonstrated that viruses often alter host nuclear organization for their own replication by mechanisms such as RNA retention and sequestration to subnuclear domains for transcription and Fig. 4 . Association of HDV RNA with PSF in HeLa cells. HeLa cells transfected with HDV RNA were used for the preparation of cross-linked lysates for coimmunoprecipitation using anti-PSF antibody, no antibody, or goat anti-mouse IgG antibody. After cross-linking, the isolated RNA samples were reverse transcribed using either the sense (+) or antisense (−) primer used to produce both polarities of the R199G region, respectively. Following PCR with the two primers, the R199G cDNA was resolved on an agarose gel. Lane M contains a DNA ladder (PhiX174 digested with HaeIII); HDV G-RNA and HDVAG-RNA lanes are RT-PCR product controls prepared from either synthetized genomic or antigenomic HDV RNA.
RNA processing. A number of cellular proteins that associate with both HDAgs and HDV RNA and that are proposed to participate in viral replication have been identified. However, the association of many of these proteins with HDV RNA has not been clearly confirmed both in vitro and in vivo. In the current investigation, we have used UV cross-linking to identify a cellular protein that binds to the right terminal stem-loop region of HDV RNA. We anticipated two properties required for a host protein that would be capable of interaction with HDV RNAs: nuclear localization and RNA-binding activity. Accordingly, mass spectrometric analysis revealed PSF, a sequencespecific nuclear RNA-binding protein that appears to be predominantly involved in RNA splice site selection, as a likely HDV-interacting candidate. This interaction was confirmed in vitro by co-immunoprecipitation of HDV RNAs with PSF within HeLa NE and by the direct binding of HDV-derived RNA fragments to recombinant PSF. Furthermore, our experiments demonstrated that PSF binds specifically to both polarities of HDV RNA through the regions located at the extremities of their rod-like structures. In addition, we have confirmed the biological relevance of the PSF interaction with HDV RNA within HeLa cells using a method based on that of Niranjanakumari et al. (2002) , which has previously been successfully performed to confirm specific interaction between HDAg and HDV RNA. This method, which uses reversible cross-linking with formaldehyde, is also commonly used in the chromatin immunoprecipitation (CHIP) assay which has proven to be a powerful method of delineating many DNA-protein interactions (Jackson, 1978; Orlando et al., 1997; Orlando, 2000; Shang et al., 2000) .
Curiously, UV cross-linking of R199G to HeLa NE did not yield a radiolabelled band corresponding to the molecular weight of PSF. Because PSF is known to multimerize and to interact with many human proteins, one possibility is that a high molecular weight complex including PSF could have been produced during the UV cross-linking experiments. Alternatively, many HeLa NE proteins could have been able to crosslink with R199G, which would account for the detection of a single high molecular weight complex. R199G includes the reported initiation site for the HDAg mRNA transcription (Gudima et al., 2000) and a similar HDV-derived RNA fragment was previously shown to be able to initiate transcription in vitro (Beard et al., 1996) . It is therefore possible that undetected host RNAP or related host factors cross-linked to R199G to generate the high molecular weight complex observed.
Typically, PTB proteins are involved in pre-mRNA splicing in the nucleus. PSF is a multifunctional 76 kDa protein that is comprised of an N-terminal RGG motif, a glycine-rich domain which might be involved in protein-protein interactions, a proline/glutamine-rich domain, a DNA-binding domain, two canonical RNA recognition motifs (RRMs), and a C-terminal region possessing two nuclear localization signals (NLSs), and a high proportion of charged residues (Patton et al., 1993; ShavTal and Zipori, 2002; Song et al., 2005) . In vivo, PSF forms a heterotetramer with p54 nrb and participates in both early and late steps of splicing. PSF associates with PTB (Patton et al., 1993) and with the small nuclear ribonucleoprotein U1A (Lutz et al., 1998) , whereas both p54 nrb and PSF specifically bind U5 snRNA in vitro (Peng et al., 2002) . The mechanism by which PSF influences pre-mRNA splice site selection is not known, although there is some evidence that it could recognize a specific RNA structure within certain splice acceptor sites. In addition to splicing, PSF was reported to be involved in a variety of nuclear processes (for a review, see Shav-Tal and Zipori, 2002) , including transcription, topoisomerase activity, nuclear retention of defectively-edited RNAs, and DNA recombination (Akhmedov and Lopez, 2000; Mathur et al., 2001; Sewer et al., 2002; Song et al., 2005; Straub et al., 1998; Urban et al., 2000; Zhang and Carmichael, 2001) . Because HDV RNA interacts with PSF, and PSF binds to many host factors and is involved in a variety of processes, it is likely that during infection HDV RNA-PSF interaction might disrupt one or several of these cellular activities. This hypothesis is consistent with a recent report showing that binding of noncoding mouse VL30 retroelement RNA to PSF induces multiple genes repressed by PSF by releasing PSF from the promoter of suppressed genes (Song et al., 2005) . It is also possible that HDAgs might modulate such interactions and processes, even if they are not required for the binding of PSF to HDV RNA in vitro. Investigation of the consequences of HDV RNA replication on the various PSF-mediated processes might thus lead to a better comprehension of HDV pathogenesis.
The specific biochemical function of PSF in HDV replication is not clear. Although precise activities of PSF in the nucleus are not fully understood, it is tempting to hypothesize at least two roles for the interaction between HDV RNAs and PSF. First, PSF interaction might be involved in HDV localization and/or retention within the nucleus. Like many proteins involved in RNA processing (Misteli and Spector, 1998) , PSF was demonstrated to localize to splicing factor-enriched nuclear subdomains known as speckles (Dye and Patton, 2001 ). Additionally, a complex including PSF and p54 nrb was reported to mediate RNA retention in the nucleus by directly binding to inosine-rich determinants in hyperedited RNAs (Zhang and Carmichael, 2001) , suggesting that RNA might be retained via anchoring to insoluble nuclear components. Because HDV is directly recognized by the components of this complex, it could share this proposed mechanism. This hypothesis is consistent with previous work suggesting the transient co-localization of HDAgs with the splicing factor SC35 in nuclear speckles early after infection (Bichko and Taylor, 1996) . However, later during infection, HDAgs are no longer associated with SC35, and it was reported that a subpopulation of HDAg-L and of antigenomic HDV RNA spatially associates with ND10 in PML bodies (Bell et al., 2000, Bichko and Taylor, 1996) . Although we cannot exclude the involvement of other host proteins or the role of HDAgs in subnuclear localization, it is tempting to interpret the localization and retention of HDV ribonucleoproteins to nuclear speckles, as observed during early infection, as a result of their binding to PSF.
Furthermore, PSF might be involved with HDV RNA transcription and/or replication. In virus-infected cells, PTB and PTB-associated proteins participate in the transcription and replication of viral RNA (reviewed in Lai, 1998) . For example, adenoviruses have been shown to recruit replication and splicing factors to the sites of active viral replication and transcription (Jimenez-Garcia and Spector, 1993; Pombo et al., 1994) . Particularly, PSF was shown to be one of the key factors mediating the post-transcriptional regulation of HIV-1 (Zolotukhin et al., 2003) . PSF and p54 nrb have also been implicated in transcriptional regulation based on the finding that both proteins avidly bind to the carboxy-terminal domain (CTD) of the largest subunit of RNAP II (Emili et al., 2002) . In vitro, PSF binds to both polarities of HDV through the terminal stem-loop domains of the rod-like structure. Both the R199G and L213AG RNA segments were reported to be able to initiate transcription in vitro using HeLa NE proteins (Beard et al., 1996; Filipovska and Konarska, 2000) . A cDNA fragment corresponding to R199AG was also able to initiate transcription in vitro in this system (Macnaughton et al., 1993) . PSF could therefore provide a direct physical link between the CTD of RNAP II and the putative HDV-derived RNA promoters at the initiation phase of transcription by interacting with both the RNAP II CTD and RNA simultaneously. However, direct evidence of the involvement of PSF in the transcription/ replication reaction will require further investigation.
In summary, we have shown that PSF binds specifically and preferentially to the two terminal stem-loop domains of both polarities of HDV RNA. Identification of PSF as a specific binding partner of HDV RNA provides new opportunities for isolating and characterizing HDV RNA-protein complexes. Specifically, further examination of the biochemical activities of PSF and identification of other cellular proteins that interact with this protein, such as p54 nrb , in the context of viral RNA replication and propagation should provide important information about the mechanisms of HDV replication and their effects on host cell metabolism.
Materials and methods

Synthesis of RNAs
The various HDV-derived RNAs were synthesized by in vitro run-off transcription using T7 RNA polymerase (New England Biolabs; NEB) from DNA templates generated by PCR amplification of sequences of pHDVd2 using Vent DNA Polymerase (NEB). pHDVd2 is a derivative of pBluescriptKS + (Stratagene) containing a dimeric EcoRI-flanked HDV cDNA insert (Kuo et al., 1988a) . P11.60 RNA was made as previously described (Pelchat and Perreault, 2004) . HDV dimeric genomes were similarly synthesized from HinDIII-linearized pHDVd2. Double-stranded regions corresponding to the central domain of HDV were generated by annealing two strands of RNA that were made by PCR of the central region of the HDV genome followed by run-off transcription. Transcription products were subjected to DNAse I (Promega) digestion for 30 min at 37°C and the RNAs were fractionated by denaturing polyacrylamide gel electrophoresis (PAGE) containing 1× TBE buffer (100 mM Tris-borate, pH 8.3, 1 mM EDTA) and 7 M urea. RNA bands were visualized by UV shadowing, excised, eluted overnight at 4°C in elution buffer (500 mM ammonium acetate, 0.1% SDS), precipitated in ethanol, resuspended in 100 μl H 2 O, passed through Sephadex G-50 columns (Amersham Pharmacia Biotech), precipitated in ethanol, suspended in 20 μl H 2 O, and stored at − 20°C. RNA was quantified spectrophotometrically at 260 nm. When 5′-radiolabelled RNA was required, 10 pmol of RNA was dephosphorylated using calf intestinal phosphatase (CIP; NEB), radiolabelled at the 5′-end using T4 polynucleotide kinase (NEB) according to the manufacturer's protocol in the presence of [γ- 32 P]ATP (GE Health Sciences) and purified by phenol/chloroform extraction, passage through a Sephadex G-50 column, and ethanol precipitation. CENTR molecules were generated using two RNA strands folded together by heat denaturation at 94°C and slow renaturation at room temperature in 40 mM Tris-HCl, pH 8.0/10 mM MgCl 2 .
UV cross-linking of RNA-protein complexes
Cross-linking of RNA to proteins was performed as previously described (Pelchat and Perreault, 2004) . Briefly, R199G was transcribed in the presence of [α- 32 P]GTP (GE Health Sciences) and 4-thio-uridine triphosphate (TriLink BioTech) to increase cross-linking efficiency, cleaned by phenol/chloroform extraction, purified using a Sephadex-G50 column, and ethanol precipitated. Formation of the complexes was performed using 1 pmol radiolabelled 4-thio-uridinecontaining R199G, 100 μg/ml total yeast tRNA, and 10 μg of HeLaScribe NE (Promega) in HeLaScribe 1× Transcription Buffer (20 mM HEPES [pH 7.9], 100 mM KCl, 0.2 mM EDTA, 0.5 mM DTT, 20% glycerol) in a total reaction volume of 10 μl. Some reactions were also performed in the presence of 100 μg/ ml heparin (Sigma-Aldrich), 100 μg/ml poly(A) RNA, 20 pmol P11.60 RNA (Pelchat and Perreault, 2004) , or 50 pmol of nonlabelled R199G. Cross-linking was performed by 20 min exposure of the reaction mixture to 365 nm light at 4°C using a UV cross-linker (Hoefer) at a distance of ∼ 4 cm. Mixtures were then treated with RNase A (QIAgen), diluted 1:10 in SDS loading dye and resolved by 10% SDS-PAGE (Sambrook et al., 1989) . Bands were detected with a phosphorimager (Molecular Dynamics) after overnight exposure to phosphorimager screens at 4°C.
Mass spectrometry and database analysis
Complexes containing HeLa NE proteins cross-linked to either non-radioactive R199G containing 4-thio-uridine with 100 μg/ml total yeast tRNA or 100 μg/ml total yeast tRNA alone were resolved by 10% SDS-PAGE and the gel was stained with methylene blue. The resulting bands were excised and three samples were sent individually to WEMB Biochem Inc. (Toronto, Canada) for protein analysis by LC-MSMS. The proteins were in-gel digested with trypsin and the resulting peptides analysed by LC-MSMS with a ThermoFinnigin Deca XP ion trap mass spectrometer. Bioworks 3.1 version software was used to process the MSMS data, and NCBI nrdatabase was used for determination of peptide sequence identity.
Co-immunoprecipitation reactions
Co-immunoprecipitation experiments were performed using the Protein-G Immunoprecipitation Kit (Sigma-Aldrich) according to manufacturer's recommended protocols with some modifications. 1 pmol 5′-radiolabelled RNA was incubated with 25 μg HeLaScribe NE in a 97.5 μl reaction volume of 1× IP buffer (50 mM Tris-Cl, pH 7.5, 1% Nonidet P-40 (NP-40), 0.5% sodium deoxycholate, 0.05% SDS, 1 mM EDTA, 150 mM NaCl) at 4°C for 30 min. Total yeast tRNA (100 μg/ml), heparin (100 μg/ml), 20 pmol P11.60, or 20 pmol of non-radioactive HDV-derived RNA was added to some mixtures. Additionally, 50 μg of NE was immunodepleted of PSF using 5 μg anti-PSF antibody (mouse monoclonal IgG SFPQ antibody [B92]; Abcam) and the Protein-G Immunoprecipitation Kit according to manufacturer's protocols; immunodepletion was confirmed by Western blot analysis (Sambrook et al., 1989) and the presence of residual NE proteins determined by SDS-PAGE followed by Coomassie blue staining. 25 μg of the immunodepleted extract was used for co-immunoprecipitation. 5 μg of either anti-PSF antibody or unspecific antibody (goat monoclonal anti-mouse IgG; Sigma-Aldrich) was added to the reaction mixtures and incubated for 2 h at 4°C with agitation prior to the addition of 30 μl pre-washed protein-G beads. Completed reactions were incubated at 4°C overnight with agitation. Samples were centrifuged at 16,000×g, washed 4 times in 1× IP buffer, once in 0.1× IP buffer, and eluted according to manufacturer's protocols. Eluates were electrophoresed by denaturing PAGE and bands were detected by phosphorimager scanning.
Purification of PSF
Plasmid pET15b-PSF (Patton et al., 1993) containing PSF cDNA with a hexahistidine tag at its N-terminus was transformed into competent Escherichia coli BL21 (Novagen) for PSF overproduction (Sambrook et al., 1989) . Protein was purified by immobilized metal affinity chromatography using the Ni-NTA Spin Kit (QIAgen) according to the manufacturer's protocol for purification under native conditions. Protein purity was estimated by Coomassie blue staining of SDS-PAGE gels (Sambrook et al., 1989) , concentration was determined using Quick Start Bradford Protein Assay Kit 1 (Bio-Rad Laboratories), and identity confirmed by Western blot analysis (Sambrook et al., 1989) . The samples were stored at − 20°C in 20 mM HEPES [pH 7.9], 100 mM KCl, 0.2 mM EDTA, 1 mM DTT, 0.5 mM PMSF, and 20% glycerol.
EMSA analysis
Formation of the complexes was performed using 1 pmol of 5′-radiolabelled RNA with various concentration of purified, recombinant hexahistidine-tagged PSF in HeLaScribe 1× Transcription Buffer. Following incubation for 5 min at 4°C, agarose loading dye (Sambrook et al., 1989 ) was added and the complexes were resolved by 5% PAGE in 1× TBE under nondenaturing conditions. Bands were visualized using phosphorimager scanning. Some reactions were also performed in the presence 100 μg/ml of total yeast tRNA (Sigma-Aldrich), 100 μg/ml heparin (Sigma-Aldrich), 20 pmol P11.60, or 50 pmol of non-radioactive HDV-derived RNA. For supershift experiments, 2.5 μg of anti-PSF antibody was added to the mixture.
HeLa in vivo RNA cross-linking experiments
Experiments were conducted using the ribonucleoprotein immunoprecipitation (RIP) assay as described by Niranjanakumari et al. (2002) with some modifications. Briefly, HeLa cells were grown to 60% confluence and transfected with 6 μg of pcDNA3-AgS and 10 μg HDV dimeric RNA genome of positive polarity using Lipofectamine TM 2000 Reagent (Invitrogen) according to the manufacturer's protocol. pcDNA3-AgS is a derivative of the pcDNA3 expression vector (Stratagene) encoding the small delta antigen under the control of a CMV promoter (Lazinski and Taylor, 1993) . Cross-linking was performed by the addition of 1% formaldehyde to ∼ 10 6 cells followed by 5 min incubation. Cells were pelleted, resuspended in 2 ml 1× IP buffer, homogenized by sonication, and centrifuged at 16,000×g for 20 min at 4°C. The soluble fraction of the cell lysate was pre-cleared by the addition of total yeast tRNA (100 μg/mL), incubation with protein-G beads for 1 h at 4°C with agitation, and centrifugation at 16,000×g. RNA fragmentation was omitted from the protocol. Co-immunoprecipitation was performed using the Protein-G Immunoprecipitation Kit (Sigma-Aldrich) using 500 μl of cell lysate and 5 μg of anti-PSF antibody. Mixtures were then incubated for 3 h at 4°C with agitation, 50 μl of pre-washed protein-G beads were added, and samples were further incubated overnight. Samples were washed 5 times with high-stringency wash buffer (50 mM Tris-Cl, pH 7.5, 1% Nonidet P-40 (NP-40), 0.5% sodium deoxycholate, 0.05% SDS, 1 mM EDTA, 150 mM NaCl, 1 M urea; Niranjanakumari et al., 2002) , heated to 70°C for 45 min in buffer containing 50 mM Tris-HCl, pH 7.0, 5 mM EDTA, 10 mM dithiotriol (DTT), and 1% SDS to reverse cross-links, and eluted from the column by centrifugation. Proteins were removed by phenol/chloroform extraction and the RNA was isolated by ethanol precipitation. The resuspended nucleic acids were treated with DNAse I (Promega) for 45 min at 37°C. Samples were again phenol/chloroform extracted, ethanol precipitated, and subjected to reverse transcription using each primer used to generate the R199G cDNA (5′-GGAATTCTAATACGACTCACTATAGGGACTGCTCGAG-GATCTCTTCTCTCCC-3′ and 5′-GGAATTCACATCCCCT-CTCGGGTGC-3′; underlined nucleotides indicate the T7 promoter) as described (Pelchat et al., 2001) . PCR was then performed using this primer pair, products resolved by 2% agarose gel electrophoresis, and the bands were visualized under UV light in the presence of ethidium bromide. Bands were excised, cloned and submitted for sequencing to the University of Ottawa Core DNA Sequencing and Synthesis Facility (Ottawa).
